Herbies Headshop

Medical Cannabis News & Information

New Study Indicates Cannabis May Reduce Aggression, Improve Social Interactions

on . Posted in Medical Cannabis News & Information

A new study published by the journal Neuropharmacology has found that cannabinoids may reduce aggression, and improve social interactions.

For the study, researchers “examined the role of cannabinoid CB1 receptors (CB1r) in aggressive behavior”, and found that a compound meant to mimic THC (a prime compound of cannabis) “significantly decreased the aggression levels” of the mice that it was administered to. The researchers also examined mice which were bred without CB1 receptors, and found them to be more inherently aggressive than normal mice.

Study Finds Cannabinoids May Combat Symptoms of Schizophrenia

on . Posted in Medical Cannabis News & Information

Contrary to prohibitionist propaganda, a new government-funded study published in the journal Neuropsychopharmacology has found that cannabis may combat the symptoms of schizophrenia by stimulating the body’s cannabinoid receptors.

Researchers for the study examined rats with schizophrenia which were dosed with a chemical substance meant to mimic cannabinoids – compounds found in cannabis, as well as naturally produced in our body. Researchers found that the cannabinoids “reversed social withdrawal in PCP-treated rats via stimulation of CB1 receptors”; social withdrawal is one of the primary symptoms of schizophrenia.

CNN's Dr. Sanjay Gupta Apologizes Being Wrong About Medical Marijuana: Americans 'Terribly Misled'

on . Posted in Medical Cannabis News & Information

Sanjay Gupta, a neurosurgeon, apologized on Wednesday for publicly opposing marijuana legalization, saying science was clearly on the side of the drug. "I think we have been terribly and systematically misled in this country for some time, and I did part of that misleading," he told CNN host Piers Morgan. Though studies on marijuana in the United States tended to focus on the drug's negative effects, Gupta explained, research from across the world had made marijuana's positive effects clear. He said there was "no scientific basis" to claim marijuana had no medical benefits. "I think it is irresponsible of the medical community not to offer this as an alternative," Gupta added, citing the high rates of deaths from prescription drugs. "I couldn't find one documented case of someone dying of a marijuana overdose."

Study Confirms Cannabis Has No Long-Term Negative Effect on Cognition

on . Posted in Medical Cannabis News & Information

London, UK, 5 August 2013: GW Pharmaceuticals plc (NASDAQ: GWPH, AIM: GWP, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces top-line results from a 12 month placebo-controlled study of Sativex in patients with spasticity due to Multiple Sclerosis (MS). The study results confirm the reassuring safety profile of Sativex and provide further evidence of long-term efficacy.

The study was a 12 month multicentre, double-blind, randomised parallel group, placebo-controlled study in 121 patients with MS spasticity. The study was required as a post-approval commitment by the UK regulatory authority, the Medicines and Healthcare products Regulatory agency (MHRA), with the primary objective of evaluating whether Sativex may have long term adverse effects on cognitive function or mood. The primary endpoint was the change in cognitive function as assessed by the total Paced Auditory Serial Addition Test (PASAT) score from baseline to end of treatment.  Mood was assessed by the Beck Depression Inventory-II.

New Study: Cannabis May Protect the Brain Against Stress and Stress-Related Disorders

on . Posted in Medical Cannabis News & Information

A new study published in this month’s issue of the journal Neuropsychopharmacology has found that compounds in cannabis may offer protection against chronic stress, including the memory and learning impairment that can come as a result.

“Our findings suggest that cannabinoid receptor activation could represent a novel approach to the treatment of cognitive deficits that accompany a variety of stress-related neuropsychiatric disorders”, concludes the study.